These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30203033)

  • 1. Unusual rapid progression of non-bacterial thrombotic endocarditis in a patient with bladder cancer despite undergoing intensification treatment with rivaroxaban for acute venous thromboembolism.
    Fujimoto D; Mochizuki Y; Nakagiri K; Shite J
    Eur Heart J; 2018 Nov; 39(43):3907. PubMed ID: 30203033
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Krause M; Henningsen A; Torge A; Juhl D; Junker R; Kenet G; Kowalski D; Limperger V; Mesters R; Anonymous ; Rocke A; Shneyder M; Clausnizer H; Schiesewitz H; Nowak-Göttl U
    Thromb Res; 2016 Dec; 148():145-151. PubMed ID: 27687905
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
    Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.
    Kabuki T; Nakanishi R; Hisatake S; Fujii T; Dobashi S; Wakakura S; Kiuchi S; Fujino T; Ikeda T
    J Cardiol; 2017 Aug; 70(2):163-168. PubMed ID: 27979674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry.
    Bott-Kitslaar DM; Saadiq RA; McBane RD; Loprinzi CL; Ashrani AA; Ransone TR; Wolfgram AA; Berentsen MM; Wysokinski WE
    Am J Med; 2016 Jun; 129(6):615-9. PubMed ID: 26797081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism.
    Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J
    Am J Med; 2018 Aug; 131(8):933-938.e1. PubMed ID: 29526541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
    Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
    Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer.
    Lee JH; Oh YM; Lee SD; Lee JS
    J Korean Med Sci; 2019 Jun; 34(21):e160. PubMed ID: 31144482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.
    Søgaard M; Nielsen PB; Skjøth F; Kjældgaard JN; Coleman CI; Larsen TB
    Am J Med; 2018 Jul; 131(7):787-794.e4. PubMed ID: 29476744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
    Nicklaus MD; Ludwig SL; Kettle JK
    J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism.
    Kimpton M; Carrier M
    Expert Opin Drug Saf; 2019 Apr; 18(4):313-320. PubMed ID: 30925842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban.
    Theodorou JM; Patel Y; Ford P
    J Pharm Pract; 2017 Jun; 30(3):381-384. PubMed ID: 27026636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of rivaroxaban for the treatment of thrombotic complications in four dogs.
    Yang VK; Cunningham SM; Rush JE; de Laforcade A
    J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):729-36. PubMed ID: 26990131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rivaroxaban thromboprophylaxis after arthroplasty of the hip or knee: retrospective cohort study.
    Loganathan V; Hua A; Patel S; Gibbons C; Vizcaychipi MP
    Ann R Coll Surg Engl; 2016 Sep; 98(7):507-15. PubMed ID: 27580310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies.
    Khorana AA; Weitz JI
    Thromb Haemost; 2018 May; 118(S 01):S23-S33. PubMed ID: 29566417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban Use in Patients with Hemoglobinopathies.
    Apostolou C; Klonizakis P; Mainou M; Kapsali E; Kafantari K; Kotsiafti A; Vetsiou E; Vakalopoulou S; Vlachaki E
    Hemoglobin; 2017 May; 41(3):223-224. PubMed ID: 28950780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.